Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: Pharmacological treatment.

Acute treatment Chronic migraine Episodic migraine Guidelines Medication overuse Prophylactic treatment

Journal

Revue neurologique
ISSN: 0035-3787
Titre abrégé: Rev Neurol (Paris)
Pays: France
ID NLM: 2984779R

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 08 07 2021
accepted: 09 07 2021
pubmed: 4 8 2021
medline: 15 9 2021
entrez: 3 8 2021
Statut: ppublish

Résumé

The French Headache Society proposes updated French guidelines for the management of migraine. This article presents the second part of the guidelines, which is focused on the pharmacological treatment of migraine, including both the acute treatment of attacks and the prophylaxis of episodic migraine as well as chronic migraine with and without medication overuse. The specific situations that can be encountered in women with migraine are also discussed, including pregnancy, menstrual migraine, contraception and hormonal replacement therapy.

Identifiants

pubmed: 34340810
pii: S0035-3787(21)00617-2
doi: 10.1016/j.neurol.2021.07.006
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

734-752

Informations de copyright

Copyright © 2021. Published by Elsevier Masson SAS.

Auteurs

A Ducros (A)

Department of neurology, Gui-de-Chauliac hospital, CHU Montpellier, university of Montpellier, 34000 Montpellier, France.

S de Gaalon (S)

Department of neurology, Laënnec hospital, CHU de Nantes, Nantes, France.

C Roos (C)

Emergency headache center (centre d'urgences céphalées), department of neurology, Lariboisière hospital, Assistance publique-Hôpitaux de Paris, Paris, France.

A Donnet (A)

Centre d'évaluation et de traitement de la douleur, FHU INOVPAIN, hôpital de La Timone, Marseille, France.

P Giraud (P)

Department of neurology, Annecy Genevois hospital, Annecy, France.

E Guégan-Massardier (E)

Department of neurology, Rouen university hospital, Rouen, France.

M Lantéri-Minet (M)

Pain department, FHU InovPain, CHU Nice Côte Azur université, Nice, France.

C Lucas (C)

Centre d'évaluation et de traitement de la douleur, service de neurochirurgie, hôpital Salengro, CHRU de Lille, Lille, France.

J Mawet (J)

Emergency headache center (centre d'urgences céphalées), department of neurology, Lariboisière hospital, Assistance publique-Hôpitaux de Paris, Paris, France.

X Moisset (X)

Neuro-Dol, université Clermont Auvergne, CHU de Clermont-Ferrand, INSERM, Clermont-Ferrand, France.

D Valade (D)

Department of neurosurgery, hôpital Pitié-Sapêtrière, Paris, France.

G Demarquay (G)

Neurological hospital, Lyon, neuroscience research center (CRNL), INSERM U1028, CNRS UMR5292, Lyon, France. Electronic address: genevieve.demarquay@chu-lyon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH